Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

VACCELERATE - European Corona Vaccine Trial Accelerator Platform

Descrizione del progetto

Una rete paneuropea per lo sviluppo di vaccini

La pandemia di COVID-19 ha messo in evidenza la necessità di compiere sforzi coordinati per lo sviluppo dei vaccini in Europa. Il progetto VACCELERATE, finanziato dall’UE, intende istituire una piattaforma che collega tutte le parti coinvolte nello sviluppo dei vaccini in Europa. Mediante la mappatura dei siti di sperimentazione clinica e dei laboratori in tutta Europa, VACCELERATE individua i luoghi più adatti per condurre studi sui vaccini di fase 2 e 3. I partecipanti alla sperimentazione vi accedono tramite un registro dei volontari. La rete coordina il supporto ai laboratori e fornisce esami standardizzati e protocolli di sperimentazione. VACCELERATE individua e condivide le questioni emergenti relative alla salute pubblica, fornisce le risposte ricavate dai propri studi clinici e mette a disposizione competenze e supporto tangibile agli sviluppatori di vaccini dell’industria e del mondo accademico. Mediante queste azioni, i partner del progetto VACCELERATE stanno creando una rete in grado di affrontare le pandemie emergenti e di rafforzare la capacità di sviluppo dei vaccini in Europa.

Obiettivo

The ongoing COVID-19 pandemic creates an unprecedented burden worldwide. Vaccine-induced immunity is the only promising solution. There is continued need for phase 2 & 3 vaccine trials to reach long-term, large-scale immunity of the entire European population.
VACCELERATE will be the pan-European backbone accelerating phase 2 & 3 COVID-19 vaccine trials. The overall objective of VACCELERATE is to connect all European stakeholders involved in vaccine development to provide a pan-European platform for clinical trial design and conduct. VACCELERATE constitutes the rapid response single entry-point to stakeholders from public health authorities to vaccine developers, to address respective needs and kick-start specifically phase 2 & 3 vaccine trials.
VACCELERATE conducts capacity mapping of clinical trial and laboratory sites to identify suitable sites for individual phase 2 & 3 vaccine trials. Capacity building via training will increase quality in sites across Europe. Volunteer registries facilitate patient recruitment. Access to laboratory sites and a standardised set of assays essential for clinical phase 2 & 3 trials is provided. A harmonised European approach to vaccine trials is enabled by aligning educational standards, coordination of laboratory support and providing standardised assays and trial protocols. Harmonised data collection, open data sharing and pooling of data for stronger analysis enables data standardisation. VACCELERATE offers solutions for characteristic vaccine development issues during pandemics by closing gaps in public health knowledge and improving knowledge transfer.
VACCELERATE amalgamates the vast but scattered expertise across Europe into one network to deliver strategic scientific leadership and guidance on vaccine trials in Europe. Beyond the COVID-19 pandemic, it will be an established pandemic preparedness network, ready to face emerging future pandemics, as well as a pivot in Europe?s capacity to develop vaccines.

Meccanismo di finanziamento

RIA - Research and Innovation action

Coordinatore

KLINIKUM DER UNIVERSITAET ZU KOELN
Contribution nette de l'UE
€ 8 006 842,72
Indirizzo
Kerpener Strasse 62
50937 Koeln
Germania

Mostra sulla mappa

Regione
Nordrhein-Westfalen Köln Köln, Kreisfreie Stadt
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 8 006 842,72

Partecipanti (33)